OTC Pharmaceuticals - Cuba

  • Cuba
  • Revenue in the OTC Pharmaceuticals market amounts to US$507.00m in 2024. The market is expected to grow annually by 2.04% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$293.80m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$45.37 are generated in 2024.
  • In the OTC Pharmaceuticals market, 1.1% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Cuba has been experiencing steady growth in recent years. Customer preferences for over-the-counter medications have been a driving force behind this trend.

Additionally, local special circumstances and underlying macroeconomic factors have contributed to the development of the market. Customer preferences in Cuba have shown a strong inclination towards self-medication and the use of over-the-counter medications. This can be attributed to several factors, including the limited access to healthcare facilities and the high cost of prescription medications.

Many Cuban consumers opt for OTC medications as a more affordable and convenient alternative. This preference for self-medication has created a demand for a wide range of OTC pharmaceutical products in the market. One of the key trends in the OTC Pharmaceuticals market in Cuba is the increasing availability and variety of OTC products.

As the market continues to develop, more pharmacies and retail outlets are stocking a larger selection of OTC medications to meet consumer demand. This trend is driven by both local and international pharmaceutical companies seeking to capitalize on the growing market. The expansion of product offerings provides consumers with greater choice and accessibility, further fueling the growth of the market.

Another trend in the market is the rising popularity of natural and herbal remedies. Cuban consumers are increasingly seeking alternative healthcare options and are turning to natural and herbal products for their perceived health benefits. This trend aligns with the global shift towards natural and holistic approaches to healthcare and wellness.

As a result, there has been an increase in the availability of natural and herbal OTC products in the Cuban market. Local special circumstances in Cuba have also played a role in the development of the OTC Pharmaceuticals market. The country's healthcare system, although highly regarded, faces challenges such as limited resources and infrastructure.

This has led to a reliance on OTC medications for common ailments and minor health issues. Additionally, the government's focus on promoting self-sufficiency and reducing healthcare costs has encouraged the growth of the OTC market as a cost-effective solution. Underlying macroeconomic factors, such as Cuba's economic reforms and increasing tourism, have also contributed to the development of the OTC Pharmaceuticals market.

The country's economic reforms have created a more favorable business environment, attracting foreign investments and fostering market growth. The rise in tourism has led to an influx of visitors, increasing the demand for OTC medications in hotels, resorts, and tourist areas. In conclusion, the OTC Pharmaceuticals market in Cuba is developing due to customer preferences for self-medication, the increasing availability of OTC products, the rising popularity of natural and herbal remedies, local special circumstances, and underlying macroeconomic factors.

As the market continues to grow, it presents opportunities for both local and international pharmaceutical companies to cater to the needs of Cuban consumers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)